iPS-Derived Dopaminergic Cells Trial for Parkinson’s
In a groundbreaking advancement for Parkinson’s disease therapy, researchers have reported the results of a first-in-human Phase I/II clinical trial ...
In a groundbreaking advancement for Parkinson’s disease therapy, researchers have reported the results of a first-in-human Phase I/II clinical trial ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine